MJBizDaily
Congress barely understands hemp THC. Lawmakers should learn and regulate – not ban
Latest Posts
Organigram CEO Engel exits struggling marijuana producer
Greg Engel, longtime CEO of Moncton, New Brunswick-based marijuana producer Organigram Holdings, is stepping away from the struggling business, effective immediately, the company said early Monday. No reason was given…
News May 3
Canadian cannabis retailer High Tide buying US CBD company for $20.6M
Calgary, Alberta-headquartered High Tide is again dipping its toes in the U.S. acquisition market, this time with a definitive agreement to buy FabCBD, a Milwaukee-based e-commerce marketplace for hemp-derived CBD…
News May 3
No hallucination: Psychedelics could be next cannabis-like boom
Investors as well as cannabis companies and executives are rushing into psychedelics, a multibillion-dollar opportunity that reminds some of the early days of marijuana - although this infant industry could…
News May 3
Catering to consumers who use marijuana as medicine
Medical marijuana isn’t exclusive to MMJ dispensaries. It’s true that consumers with serious health problems are more likely to shop at dispensaries than adult-use retailers in order to access more…
News May 1
While physicians see patients benefiting from cannabis, national medical associations remain unconvinced
A growing number of physicians see medical cannabis as legitimate medicine, but many remain skeptical if not reluctant to recommend it. That’s left some state medical marijuana programs with a…
News May 1
Minor cannabinoids will likely have a large role in the wellness industry
Move over CBD. Make way for CBN and CBG. Hemp and marijuana executives say the booming wellness market is a natural fit for cannabis-based medicine, and minor cannabinoids might play…
News May 1
Experts point to breeding and extraction as ways to capture minor cannabinoids
As minor cannabinoids gain popularity and acceptance among cannabis consumers, extraction companies looking to cash in on the trend can approach creating them in several ways.
News May 1
Consumers are using cannabis to manage sleep and anxiety issues during the pandemic
Chronic pain continues to be the No. 1 reason patients register for medical marijuana cards. But the COVID-19 pandemic and a major recession forced many people to confront a host…
News May 1
From Pfizer to PharmaCann: Bringing Big Pharma expertise to cannabis
The key to developing effective medical and wellness products for cannabis consumers begins with understanding what patients want and expect—and what the ever-growing universe of plant-based medicines can deliver.
News May 1
Latest Sponsored
